See more : Expensify, Inc. (EXFY) Income Statement Analysis – Financial Results
Complete financial analysis of EnWave Corporation (NWVCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EnWave Corporation, a leading company in the Industrial – Machinery industry within the Industrials sector.
- Chobi Company Limited (001550.KS) Income Statement Analysis – Financial Results
- AS-IP Tech, Inc. (IPTK) Income Statement Analysis – Financial Results
- Yari Minerals Limited (YAR.AX) Income Statement Analysis – Financial Results
- Suzhou Everbright Photonics (688048.SS) Income Statement Analysis – Financial Results
- Shikoku Chemicals Corporation (4099.T) Income Statement Analysis – Financial Results
EnWave Corporation (NWVCF)
About EnWave Corporation
EnWave Corporation designs, constructs, markets, licenses, installs, and sells vacuum-microwave machinery for the food, cannabis, and biomaterial dehydration industries in Canada and the United States. It offers radiant energy vacuum (REV) dehydration platforms, such as nutraREV and quantaREV to dehydrate fruits, vegetables, herbs, dairy products, ready-to-eat meals, instant baked goods, cannabis products, nutraceuticals, pharmaceuticals, and meats and seafood. The company also provides REV platforms for pharmaceutical industry, including powderREV; and freezeREV for the dehydration of biomaterial and pharmaceutical products. In addition, it manufactures and sells cheddar, gouda, bacon cheddar, parmesan garlic, black pepper, white cheddar, and pepper jack flavors. The company sells its products through various direct customer relationships, brokers, distributors, and retailers; its online store, mooncheese.com; and Amazon.com, Inc. EnWave Corporation was founded in 1999 and is headquartered in Delta, Canada.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.18M | 11.36M | 23.70M | 26.48M | 32.88M | 42.84M | 22.83M | 15.95M | 14.93M | 5.87M | 4.55M | 5.45M | 486.90K | 217.02K | 131.05K | 496.56K | 74.04K | 74.23K | 37.31K | 1.40K | 6.24K | 282.62K | 0.00 | 6.53K | 1.00 | 100.00K | 100.00K | 100.00K |
Cost of Revenue | 5.52M | 6.93M | 17.41M | 19.31M | 24.11M | 29.24M | 13.92M | 11.65M | 10.38M | 4.69M | 3.98M | 3.80M | 971.29K | 0.00 | 10.63K | 502.50K | 0.00 | 22.67K | 46.64K | 0.00 | 0.00 | 102.07K | 0.00 | 0.00 | -148.39K | 0.00 | 0.00 | 0.00 |
Gross Profit | 2.66M | 4.43M | 6.29M | 7.17M | 8.77M | 13.61M | 8.91M | 4.30M | 4.55M | 1.18M | 578.36K | 1.65M | -484.39K | 217.02K | 120.42K | -5.94K | 74.04K | 51.56K | -9.33K | 1.40K | 6.24K | 180.55K | 0.00 | 6.53K | 148.39K | 100.00K | 100.00K | 100.00K |
Gross Profit Ratio | 32.50% | 39.01% | 26.54% | 27.07% | 26.67% | 31.76% | 39.04% | 26.95% | 30.47% | 20.09% | 12.70% | 30.33% | -99.48% | 100.00% | 91.89% | -1.20% | 100.00% | 69.46% | -25.00% | 100.00% | 100.00% | 63.88% | 0.00% | 100.00% | 14,838,600.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 1.49M | 1.58M | 2.18M | 1.88M | 1.99M | 1.69M | 1.21M | 1.14M | 1.66M | 1.39M | 1.59M | 2.67M | 2.54M | 2.51M | 1.73M | 869.46K | 766.06K | 621.77K | 174.77K | 113.12K | 37.16K | 76.30K | 6.38K | 349.96K | 669.73K | 600.00K | 0.00 | 0.00 |
General & Administrative | 2.59M | 2.74M | 5.65M | 5.92M | 6.85M | 6.15M | 2.98M | 2.96M | 2.39M | 2.35M | 2.73M | 3.11M | 1.83M | 1.77M | 1.49M | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 1.47M | 1.40M | 5.47M | 4.65M | 6.47M | 5.79M | 3.73M | 2.16M | 793.00K | 719.00K | 1.17M | 979.04K | 424.64K | 279.91K | 162.76K | 104.99K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 4.06M | 4.14M | 11.12M | 10.57M | 13.32M | 11.94M | 6.72M | 5.12M | 3.18M | 3.07M | 3.89M | 4.09M | 2.26M | 2.05M | 1.65M | 1.12M | 1.39M | 870.74K | 183.09K | 194.99K | 77.98K | 136.86K | 146.99K | 484.07K | 973.32K | 900.00K | 100.00K | 0.00 |
Other Expenses | -2.90M | 0.00 | -11.00K | -1.12M | -1.37M | 391.00K | 0.00 | 0.00 | -178.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 468.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 2.66M | 5.73M | 13.28M | 11.32M | 13.94M | 14.02M | 8.50M | 7.15M | 6.06M | 5.88M | 7.23M | 9.14M | 5.95M | 5.19M | 3.38M | 1.99M | 2.15M | 1.49M | 368.91K | 308.11K | 115.14K | 213.16K | 153.37K | 834.02K | 1.79M | 1.60M | 100.00K | 0.00 |
Cost & Expenses | 8.18M | 13.00M | 30.70M | 30.63M | 38.05M | 43.26M | 22.42M | 18.80M | 16.44M | 10.56M | 11.20M | 12.93M | 6.92M | 5.19M | 3.39M | 2.49M | 2.15M | 1.52M | 415.54K | 308.11K | 115.14K | 315.23K | 153.37K | 834.02K | 1.64M | 1.60M | 100.00K | 0.00 |
Interest Income | 211.00K | 185.00K | 144.00K | 7.00K | 116.00K | 179.00K | 60.00K | 0.00 | 0.00 | 107.00K | 111.38K | 115.35K | 158.94K | 133.40K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 140.00K | 128.00K | 118.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81.00K | 277.43K | 126.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.16M | 1.12M | 1.10M | 2.51M | 2.04M | 2.02M | 1.98M | 1.96M | 2.30M | 2.23M | 1.75M | 2.14M | 1.35M | 755.13K | 88.81K | 52.98K | 30.71K | 15.89K | 16.79K | 16.69K | 16.93K | 78.80K | 108.25K | 137.58K | 148.39K | 100.00K | 0.00 | 0.00 |
EBITDA | -1.05M | -334.00K | -1.43M | -1.64M | -4.75M | 1.61M | 2.38M | -885.00K | 807.00K | -2.46M | -3.26M | -5.22M | -5.09M | -4.22M | -3.17M | -1.94M | -2.05M | -1.43M | -361.44K | -290.02K | -91.97K | 46.19K | -45.11K | -689.92K | -1.49M | -1.40M | 0.00 | 100.00K |
EBITDA Ratio | -12.83% | -2.94% | -19.02% | -3.63% | -9.62% | 5.77% | 14.30% | -4.91% | 7.49% | -40.17% | -105.09% | -95.88% | -940.08% | -1,942.54% | -2,417.54% | -391.26% | -2,764.02% | -1,919.67% | -968.72% | -20,715.79% | -1,474.29% | 16.34% | 0.00% | -10,570.22% | -149,466,000.00% | -1,400.00% | 0.00% | 100.00% |
Operating Income | 0.00 | -1.48M | -7.06M | -3.48M | -5.20M | 448.00K | 1.29M | -2.75M | -1.20M | -4.59M | -6.54M | -7.37M | -6.43M | -4.97M | -3.26M | -2.00M | -2.08M | -1.44M | -378.23K | -306.71K | -108.90K | -32.61K | -153.37K | -827.50K | -1.64M | -1.50M | 0.00 | 100.00K |
Operating Income Ratio | 0.00% | -13.06% | -29.77% | -13.13% | -15.82% | 1.05% | 5.63% | -17.22% | -8.02% | -78.20% | -143.55% | -135.25% | -1,320.54% | -2,290.49% | -2,485.31% | -401.93% | -2,805.50% | -1,941.08% | -1,013.73% | -21,907.79% | -1,745.74% | -11.54% | 0.00% | -12,678.06% | -164,304,500.00% | -1,500.00% | 0.00% | 100.00% |
Total Other Income/Expenses | -2.35M | -95.00K | 269.00K | -1.36M | 182.00K | -683.00K | -816.00K | -137.00K | -328.00K | -297.00K | -91.00K | -525.62K | -340.09K | 132.04K | 468.00 | 0.00 | -3.85K | -323.00 | 150.00K | 0.00 | 0.00 | 3.00K | -49.16K | -171.92K | 257.45K | 300.00K | 0.00 | -100.00K |
Income Before Tax | -2.35M | -1.58M | -6.96M | -4.83M | -5.02M | -1.10M | -407.00K | -2.99M | -1.84M | -4.99M | -6.99M | -8.01M | -6.77M | -4.84M | -3.26M | 0.00 | -2.08M | -1.44M | -228.23K | 0.00 | 0.00 | -29.61K | -202.53K | -999.42K | -1.39M | -1.20M | 0.00 | 0.00 |
Income Before Tax Ratio | -28.73% | -13.90% | -29.34% | -18.25% | -15.27% | -2.56% | -1.78% | -18.72% | -12.30% | -85.09% | -153.50% | -147.01% | -1,390.39% | -2,229.92% | -2,484.96% | 0.00% | -2,810.71% | -1,941.52% | -611.70% | 0.00% | 0.00% | -10.48% | 0.00% | -15,312.06% | -138,559,300.00% | -1,200.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 0.00 | -28.00K | -707.00K | -579.00K | 889.00K | 538.00K | 542.00K | 606.00K | 3.75M | 277.43K | -119.50K | 340.09K | -133.40K | -28.61K | -23.14K | -29.17K | -30.71K | -11.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 |
Net Income | -2.40M | -6.51M | -6.93M | -4.13M | -4.44M | -1.99M | -1.30M | -3.39M | -2.12M | -8.66M | -6.99M | -7.89M | -6.77M | -4.84M | -3.23M | -1.97M | -2.05M | -1.41M | -216.25K | -306.71K | -108.90K | -29.61K | -202.53K | -999.42K | -1.39M | -1.20M | 0.00 | 0.00 |
Net Income Ratio | -29.31% | -57.31% | -29.22% | -15.58% | -13.51% | -4.64% | -5.67% | -21.25% | -14.16% | -147.55% | -153.50% | -144.82% | -1,390.39% | -2,229.03% | -2,463.12% | -397.27% | -2,771.30% | -1,900.15% | -579.59% | -21,907.79% | -1,745.74% | -10.48% | 0.00% | -15,312.06% | -138,559,400.00% | -1,200.00% | 0.00% | 0.00% |
EPS | 0.00 | -0.06 | -0.06 | -0.04 | -0.04 | -0.02 | -0.01 | -0.04 | -0.02 | -0.10 | -0.08 | -0.10 | -0.09 | -0.07 | -0.06 | -0.05 | -0.06 | -0.05 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | -0.06 | -0.09 | -0.09 | -0.01 | 0.00 |
EPS Diluted | 0.00 | -0.06 | -0.06 | -0.04 | -0.04 | -0.02 | -0.01 | -0.04 | -0.02 | -0.10 | -0.08 | -0.10 | -0.09 | -0.07 | -0.06 | -0.05 | -0.06 | -0.05 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | -0.06 | -0.09 | -0.09 | -0.01 | 0.00 |
Weighted Avg Shares Out | 0.00 | 110.55M | 110.35M | 111.57M | 111.26M | 105.44M | 99.51M | 90.80M | 90.38M | 84.47M | 82.76M | 77.32M | 73.10M | 66.63M | 53.38M | 41.26M | 35.41M | 30.03M | 25.72M | 22.64M | 20.05M | 18.18M | 16.11M | 16.11M | 16.11M | 13.73M | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 0.00 | 110.55M | 110.35M | 111.57M | 111.26M | 105.44M | 99.51M | 90.80M | 90.38M | 84.47M | 82.76M | 77.32M | 73.10M | 66.63M | 53.38M | 41.26M | 35.41M | 30.03M | 25.72M | 22.64M | 20.05M | 18.18M | 16.11M | 16.11M | 16.11M | 13.73M | 0.00 | 0.00 |
EnWave Signs Commercial Lease Agreement with Major Pet Treat Company to Accelerate New Product Development
EnWave Signs Commercial License Agreement with Michael Foods
EnWave Engages SagePoint Capital Partners to Provide Strategic Capital Markets and Corporate Development Advisory Services
EnWave Reports Acquisition of Eregli Agrosan by Alarko Holdings
EnWave Announces Refreshment of Executive Stock Option Position
EnWave Corporation (NWVCF) Q3 2023 Earnings Call Transcript
EnWave Reports 2023 Third Quarter Consolidated Interim Financial Results
EnWave to Exhibit at ANUTEC – International FoodTec India 2023
EnWave to Report Third Quarter Financial Results on August 24, 2023 and Host Investor Conference Call
EnWave Signs Technology Evaluation and License Option Agreement with Moleciwl Cyf
Source: https://incomestatements.info
Category: Stock Reports